|
Carvedilol EP impurity B
|
卡維地洛EP雜質(zhì)B
|
918903-20-5
|
|
Cefazolin USP Related Compound D(Diastereoisomer Mixture)
|
頭孢唑啉USP相關(guān)化合物D(非對映異構(gòu)體混合物)
|
|
|
Diosmin EP Impurity D
|
地奧司明EP雜質(zhì)D
|
1431536-92-3
|
|
Everolimus impurity 42
|
依維莫司雜質(zhì)42
|
1708118-13-1
|
|
Butafosfan
|
布他磷
|
17316-67-5
|
|
Nintedanib Impurity 76
|
尼達(dá)尼布雜質(zhì)76
|
56961-85-4
|
|
Dexamethasone Sodium Phosphate EP Impurity I
|
地塞米松磷酸鈉EP雜質(zhì)I
|
|
|
Drospirenone EP Impurity C
|
屈螺酮EP雜質(zhì)C
|
116298-21-6
|
|
Bortezomib Impurity 6
|
硼替佐米雜質(zhì)6
|
1132709-14-8
|
|
6-Aminocaproic Acid Dimer
|
6-氨基己酸二聚體
|
2014-58-6
|
|
Nicorandil
|
尼可地爾
|
65141-46-0
|
|
Vonoprazan Impurity 4
|
沃諾拉贊雜質(zhì)4
|
1807642-39-2
|
|
Alprazolam EP Impurity E
|
阿普唑侖EP雜質(zhì)E
|
719-59-5
|
|
Norfloxacin EP Impurity I
|
諾氟沙星EP雜質(zhì)I
|
|
|
Riboflavin-3＇-phosphate
|
核黃素-3＇-磷酸
|
80400-93-7
|
|
Fluorouracil Impurity 14
|
氟尿嘧啶雜質(zhì)14
|
6623-81-0
|
|
Amorolfine EP Impurity F
|
阿莫羅芬EP雜質(zhì)F
|
106614-66-8
|
|
Benazepril EP Impurity B(1R,3S-Isomer)
|
貝那普利EP雜質(zhì)B（1R,3S-異構(gòu)體）
|
86541-76-6
|
|
Landiolol Impurity 37
|
蘭地洛爾雜質(zhì)37
|
|
|
Losartan EP Impurity J
|
氯沙坦EP雜質(zhì)J
|
1006062-27-6
|
|
Dabigatran Impurity 66
|
達(dá)比加群雜質(zhì)66
|
211914-50-0
|
|
Dexamethasone Acetate EP Impurity F
|
醋酸地塞米松EP雜質(zhì)F
|
2884-51-7
|
|
Axitinib Impurity 1
|
阿西替尼雜質(zhì)1
|
1347304-18-0
|
|
Canagliflozin Impurity 15
|
卡格列凈雜質(zhì)15
|
1830346-16-1
|
|
Pramipexole Impurity 71
|
普拉克索雜質(zhì)71
|
77835-18-8
|
|
Cefuroxime Sodium EP Impurity B
|
頭孢呋辛鈉EP雜質(zhì)B
|
39685-31-9
|
|
Paroxetine Impurity 64
|
帕羅西汀雜質(zhì)64
|
2361294-43-9
|
|
Molsidomine EP Impurity B
|
嗎多明EP雜質(zhì)B
|
59-89-2
|
|
Atomoxetine-d3 HCl
|
鹽酸托莫西汀-d3
|
1217776-38-9
|
|
Isosorbide Dinitrate Impurity 13
|
硝酸異山梨酯雜質(zhì)13
|
16051-77-7
|
|
Cefuroxime Sodium EP Impurity C
|
頭孢呋辛鈉EP雜質(zhì)C
|
69822-88-4
|
|
S-Polaprezinc Impurity 8
|
S-聚普瑞鋅雜質(zhì)8
|
7389-97-1
|
|
Spironolactone EP Impurity I
|
安體舒通EP雜質(zhì)I
|
|
|
(4-aminobenzoyl)-D-glutamic acid
|
（4-氨基苯甲酰）-D-谷氨酸
|
5959-18-2
|
|
Oxcarbazepine Impurity 12
|
奧卡西平雜質(zhì)12
|
33948-22-0
|
|
Ceftriaxone Disodium Salt Hemiheptahydrate
|
頭孢曲松鈉3.5水合物
|
104376-79-6
|
|
D-Glucaric acid
|
D-葡糖二酸
|
87-73-0
|
|
Cefotaxime EP Impurity C
|
頭孢噻肟EP雜質(zhì)C
|
66403-32-5
|
|
Flunarizine Impurity 16
|
氟桂利嗪雜質(zhì)16
|
345-90-4
|
|
(R,R)Palonosetron HCl
|
(R,R)帕洛諾司瓊鹽酸
|
135729-75-8
|
|
Linagliptin Impurity 76 (Mixture of Diastereomers)
|
利格列汀雜質(zhì)3（非對映異構(gòu)體混合物）
|
|
|
Carbidopa EP Impurity B
|
卡比多巴EP雜質(zhì)B
|
18181-08-3
|
|
Argatroban Impurity 14 (Mixture of Diastereomers)
|
阿加曲班雜質(zhì)14 (非對映異構(gòu)體混合物）
|
189264-03-7
|
|
Pramipexole Impurity BI-IO460BS
|
普拉克索雜質(zhì)BI-IO460BS
|
1246833-75-9
|
|
Omadacycline
|
奧瑪環(huán)素
|
389139-89-3
|
|
Riboflavin-4＇-phosphate
|
核黃素-4＇-磷酸
|
60697-29-2
|
|
Clemastine Impurity 4
|
氯馬斯汀雜質(zhì)4
|
67004-64-2
|
|
Dotinurad
|
多蒂納德
|
1285572-51-1
|
|
Pimecrolimus Impurity 6
|
吡美莫司雜質(zhì)6
|
|
|
Sodium 1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,13,13,13-heptacosafluorotridecane-1-sulcid
|
|
791563-89-8
|
|
Posaconazole Impurity 156
|
泊沙康唑雜質(zhì)156
|
766473-61-4
|
|
Leuprorelin EP Impurity H Trifluoroacetic acid
|
亮丙瑞林EP雜質(zhì)H 三氟乙酸鹽
|
112710-58-4
|
|
Vonoprazan Impurity 16
|
沃諾拉贊雜質(zhì)16
|
16133-25-8
|
|
Levonorgestrel EP Impurity C
|
左炔諾孕酮EP雜質(zhì)C
|
1337972-89-0
|
|
Tenofovir disoproxil Impurity 13
|
替諾福韋雜質(zhì)13
|
1244022-54-5
|
|
Carfilzomib Impurity 48
|
卡非佐米雜質(zhì)48
|
1541172-75-1
|
|
Olmesartan Impurity 41
|
奧美沙坦雜質(zhì)41
|
1443544-27-1
|
|
Hyoscine Butylbromide EP Impurity D Bromide
|
丁溴東莨菪堿EP雜質(zhì)D
|
30269-50-2
|
|
Canagliflozin Impurity 57
|
卡格列凈雜質(zhì)57
|
|
|
Oseltamivir Impurity 195
|
奧司他韋雜質(zhì)195
|
312904-18-0
|
|
(S)-Citalopram Oxalate
|
（S）-西酞普蘭 草酸鹽
|
219861-08-2
|
|
Sugammadex Impurity Org197339-1
|
舒更葡糖雜質(zhì) Org197339-1
|
|
|
Pirfenidone Impurity 33
|
吡非尼酮雜質(zhì)33
|
108-86-1
|
|
Cyclophosphamide EP Impurity E DiHCl
|
環(huán)磷酰胺EP雜質(zhì)E二鹽酸鹽
|
158401-51-5
|
|
Carvedilol EP impurity A
|
卡維地洛EP雜質(zhì)A
|
1198090-73-1
|
|
Ganciclovir EP Impurity H
|
更昔洛韋EP雜質(zhì)H
|
84222-50-4
|
|
Vonoprazan Fumarate Impurity 30
|
富馬酸沃諾拉贊雜質(zhì)30
|
|
|
Azacitidine Impurity 51
|
阿扎胞苷雜質(zhì)51
|
931-86-2
|
|
Arbidol Impurity 3
|
阿比朵爾雜質(zhì)3
|
153633-10-4
|
|
Ornidazole Impurity 14
|
奧硝唑雜質(zhì)14
|
116989-52-7
|
|
Fluazinam Impurity 1
|
氟啶胺雜質(zhì)1
|
169327-87-1
|
|
Tolvaptan Impurity 26
|
托伐普坦雜質(zhì)26
|
1580889-25-3
|
|
Caffeine Impurity 5
|
咖啡因雜質(zhì)5
|
611-59-6
|
|
Meropenem Impurity 4
|
美羅培南雜質(zhì)4
|
108-48-5
|
|
Methylprednisolone EP Impurity F
|
甲基潑尼松龍EP雜質(zhì)F
|
1625-39-4
|
|
Pramipexole Dihydrochloride Monohydrate
|
普拉克索二鹽酸鹽單水合物
|
191217-81-9
|
|
Levothyroxine Impurity 29(Mixture of Diastereomers)
|
左旋甲狀腺素雜質(zhì)29（非對映異構(gòu)體混合物）
|
|
|
Cumene Hydroperoxide technical grade, 80%
|
過氧化氫異丙苯（technical grade, 80%）
|
80-15-9
|
|
Azilsartan Impurity 1
|
阿齊沙坦雜質(zhì)1
|
1586011-04-2
|
|
Imatinib
|
伊馬替尼
|
152459-95-5
|
|
Tenofovir disoproxil
|
替諾福韋二吡呋酯
|
202138-50-9
|
|
Ubidecarenone (Coenzyme Q10) EP Impurity E
|
癸利酮（輔酶Q10）EP雜質(zhì)E
|
65085-30-5
|
|
Faropenem Sodium
|
法羅培南鈉
|
158365-51-6
|
|
Lurasidone Impurity 48
|
魯拉西酮雜質(zhì)48
|
1318074-25-7
|
|
Vonoprazan Fumarate Impurity 2
|
富馬酸沃諾拉贊雜質(zhì)2
|
1240948-77-9
|
|
Beclomethasone dipropionate EP Impurity I
|
丙酸倍氯米松EP雜質(zhì)I
|
52092-12-3
|
|
Vericiguat
|
維利西呱
|
1350653-20-1
|
|
Montelukast EP Impurity A
|
孟魯司特EP雜質(zhì)A
|
220927-27-5
|
|
Buspirone hydrochloride
|
鹽酸丁螺環(huán)酮
|
33386-08-2
|
|
Dexmedetomidine Impurity 9
|
右美托咪定雜質(zhì)9
|
2240179-63-7
|
|
Tolvaptan Impurity 23
|
托伐普坦雜質(zhì)23
|
1580889-33-3
|
|
Silicristin
|
水飛薊亭
|
33889-69-9
|
|
Calcifediol Monohydrate
|
骨化二醇 一水合物
|
63283-36-3
|
|
Isosorbide Dinitrate EP Impurity B
|
硝酸異山梨酯EP雜質(zhì)B
|
16106-20-0
|
|
Ilaprazole Impurity 24
|
艾普拉唑雜質(zhì)24
|
|
|
Limaprost
|
利馬前列素
|
74397-12-9
|
|
Safinamide mesylate
|
沙芬酰胺甲磺酸鹽
|
202825-46-5
|
|
Lumateperone Tosylate Salt
|
盧美哌隆對甲苯磺酸鹽
|
1187020-80-9
|
|
Brimonidine EP Impurity G Trifluoroacetic acid salt
|
溴莫尼定EP雜質(zhì)G 三氟乙酸鹽
|
1391054-10-6
|
|
Nafamostat Impurity 19
|
萘莫司他雜質(zhì)19
|
63101-32-6
|